Clinical Trials
390
Active:0
Completed:302
Trial Phases
6 Phases
Early Phase 1:3
Phase 1:109
Phase 2:130
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (314 trials with phase data)• Click on a phase to view related trials
Phase 2
130 (41.4%)Phase 1
109 (34.7%)Not Applicable
40 (12.7%)Phase 4
17 (5.4%)Phase 3
15 (4.8%)Early Phase 1
3 (1.0%)Causal Mechanisms of Odor-Guided Behavior in Humans
Not Applicable
Not yet recruiting
- Conditions
- Normal Physiology
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 80
- Registration Number
- NCT07099092
- Locations
- 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
Not yet recruiting
- Conditions
- Substance Use Disorders (SUDs)
- First Posted Date
- 2025-05-30
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 30
- Registration Number
- NCT06995885
- Locations
- 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States
Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)
Phase 1
Not yet recruiting
- Conditions
- Healthy Volunteers
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 35
- Registration Number
- NCT06868914
- Locations
- 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States
Environment and Alcohol: A Pilot Study
Phase 1
Recruiting
- Conditions
- Alcohol Use Disorder
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 44
- Registration Number
- NCT06860607
- Locations
- 🇺🇸
National Institute on Drug Abuse, Baltimore, Maryland, United States
VK4-116 Phase I Study With Food-Effect
Phase 1
Not yet recruiting
- Conditions
- Opioid DependenceOpioid Use Disorder (OUD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 48
- Registration Number
- NCT06808932
- Locations
- 🇺🇸
Altasciences Clinical Kansas, Overland Park, Kansas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 78
- Next
News
No news found